Skip to main content
Premium Trial:

Request an Annual Quote

Proteomics Market to Grow Six-Fold, Reach $5.6B by 2006, Frost & Sullivan Report Predicts

Premium

The global proteomics market is projected to grow nearly six-fold to $5.6 billion by 2006, according to market research conducted by Frost & Sullivan. In 2000, the total market was $963 million, the consultancy said.

In a report released in August, Frost & Sullivan said the discovery that the human genome contains fewer genes than originally predicted has elevated the potential importance of proteins and led to an interest in proteome-wide studies.

The report, which separates proteomics by tool providers and drug discovery companies, offers the most aggressive forecast to date for the sector.

In June, Front Line Strategic Management Consulting forecast that the proteomics market would increase from a $561-million market to a $2.8-billion market by 2005.

In its report, Front Line forecast that a few players would continue to control the mass spectrometry market and that the 2D gel market would shrink as faster, simpler tools were developed.

Front Line said that the protein chip market would also grow, naming Ciphergen Biosystems as a leader in the space. The report also singled out Integrative Proteomics for its efforts to speed up protein analysis. — Kirell Lakhman

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.